Overview

Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma

Status:
Completed
Trial end date:
2019-04-01
Target enrollment:
Participant gender:
Summary
In this study the investigators aim to evaluate diagnostic utility of prostate-specific membrane antigen (PSMA)-targeted 18F-DCFPyL PET/CT in patients with renal cell carcinoma (RCC).
Phase:
N/A
Details
Lead Sponsor:
Johns Hopkins University